SE444170B - Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika - Google Patents

Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika

Info

Publication number
SE444170B
SE444170B SE7808530A SE7808530A SE444170B SE 444170 B SE444170 B SE 444170B SE 7808530 A SE7808530 A SE 7808530A SE 7808530 A SE7808530 A SE 7808530A SE 444170 B SE444170 B SE 444170B
Authority
SE
Sweden
Prior art keywords
salts
pyridyl
compounds
formula
acids
Prior art date
Application number
SE7808530A
Other languages
English (en)
Swedish (sv)
Other versions
SE7808530L (sv
Inventor
K Schromm
A Mentrup
E-O Renth
A Fugner
V Jacobi
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7808530L publication Critical patent/SE7808530L/xx
Publication of SE444170B publication Critical patent/SE444170B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7808530A 1977-08-10 1978-08-09 Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika SE444170B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (2)

Publication Number Publication Date
SE7808530L SE7808530L (sv) 1979-02-11
SE444170B true SE444170B (sv) 1986-03-24

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7808530A SE444170B (sv) 1977-08-10 1978-08-09 Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika

Country Status (32)

Country Link
US (1) US4241068A (fi)
JP (1) JPS5430177A (fi)
AT (1) AT370415B (fi)
AU (1) AU520240B2 (fi)
BE (1) BE869640A (fi)
BG (1) BG30472A1 (fi)
CA (1) CA1111037A (fi)
CH (1) CH649289A5 (fi)
CS (1) CS202506B2 (fi)
DD (1) DD140351A5 (fi)
DE (1) DE2735919A1 (fi)
DK (1) DK148019C (fi)
ES (5) ES472143A1 (fi)
FI (1) FI71555C (fi)
FR (1) FR2400017A1 (fi)
GB (1) GB2002764B (fi)
GR (1) GR65024B (fi)
HU (1) HU179933B (fi)
IE (1) IE47228B1 (fi)
IT (1) IT1107960B (fi)
LU (1) LU80094A1 (fi)
MX (1) MX5672E (fi)
NL (1) NL7808319A (fi)
NO (1) NO152605C (fi)
NZ (1) NZ188101A (fi)
PH (1) PH19117A (fi)
PL (2) PL115889B1 (fi)
PT (1) PT68407A (fi)
SE (1) SE444170B (fi)
SU (2) SU735168A3 (fi)
YU (1) YU40832B (fi)
ZA (1) ZA784501B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk ２−アニリノ−１，６−ジヒドロ−６−オキソ−５−ピリミジンカルボン酸誘導体，その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (fi) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
BE869640A (fr) 1979-02-09
CH649289A5 (de) 1985-05-15
DD140351A5 (de) 1980-02-27
DK148019C (da) 1985-07-01
ES480623A1 (es) 1980-01-01
ES475457A1 (es) 1979-11-16
IE47228B1 (en) 1984-01-25
DE2735919C2 (fi) 1988-10-27
NZ188101A (en) 1981-01-23
NO152605B (no) 1985-07-15
SU735168A3 (ru) 1980-05-15
AT370415B (de) 1983-03-25
GB2002764B (en) 1982-08-04
BG30472A1 (en) 1981-06-15
MX5672E (es) 1983-12-08
CA1111037A (en) 1981-10-20
LU80094A1 (de) 1979-09-07
PH19117A (en) 1986-01-06
JPS5430177A (en) 1979-03-06
HU179933B (en) 1983-01-28
FR2400017A1 (fr) 1979-03-09
SU886743A3 (ru) 1981-11-30
FI71555B (fi) 1986-10-10
FI71555C (fi) 1987-01-19
US4241068A (en) 1980-12-23
SE7808530L (sv) 1979-02-11
AU520240B2 (en) 1982-01-21
YU40832B (en) 1986-06-30
IT1107960B (it) 1985-12-02
ATA549278A (de) 1982-08-15
GR65024B (en) 1980-06-16
DK351978A (da) 1979-02-11
JPS6231704B2 (fi) 1987-07-09
DK148019B (da) 1985-02-04
ES480622A1 (es) 1980-01-01
PL115889B1 (en) 1981-05-30
PL208942A1 (fi) 1979-12-03
GB2002764A (en) 1979-02-28
ZA784501B (en) 1980-04-30
CS202506B2 (en) 1981-01-30
IT7850642A0 (it) 1978-08-08
NL7808319A (nl) 1979-02-13
NO152605C (no) 1985-10-23
NO782707L (no) 1979-02-13
PL115778B1 (en) 1981-04-30
IE781618L (en) 1979-02-10
AU3877278A (en) 1980-02-14
YU191678A (en) 1983-01-21
DE2735919A1 (de) 1979-02-22
FI782039A (fi) 1979-02-11
FR2400017B1 (fi) 1983-03-11
ES472143A1 (es) 1979-03-16
ES475456A1 (es) 1979-05-01
PT68407A (de) 1978-09-01

Similar Documents

Publication Publication Date Title
CH625243A5 (fi)
DE102004008141A1 (de) Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
WO1997013767A1 (de) Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren
NO133669B (fi)
DE60118560T2 (de) Nicht-nukleosid reverse transkriptase inhibitoren
SE444170B (sv) Nya 2-pyridyl- och 2-pyrimidylaminobensoesyror, forfarande for framstellning derav samt anvendning av foreningarna som aktiv komponent i terapeutiska kompositioner, speciellt som antiallergika
EP0093252B1 (de) Thiomethylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE10043659A1 (de) Arylpiperazinderivate
CH616935A5 (en) Process for the preparation of chromone derivatives
DD222311A5 (de) Verfahren zur herstellung neuer flavanone und thioflavanone
KR820001542B1 (ko) 2-피리딜-및 2-피리미딜아미노 벤조산류의 제조방법
EP0194571A1 (de) Heterocyclische Disulfide, Verfahren zu ihrer Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten
EP0113911B1 (de) Pyrido-triazolochinazoline, ihre Herstellung und Verwendung
AT373584B (de) Verfahren zur herstellung neuer 2-pyridylaminobenzoesaeuren und ihre salze
KR820001518B1 (ko) 2-피리딜 및 2-피리미딜아미노 벤조산류의 제조방법
JPS60142968A (ja) 新規ジアジン−エテニルフエニルオキサミン酸
DE19612101A1 (de) Endothelin-Rezeptor-Antagonisten
DE2757929A1 (de) Neue pyrido-eckige klammer auf 1,2-a eckige klammer zu -v-triazolo- eckige klammer auf 4,5-d eckige klammer zu pyrimidinone, deren salze und verfahren zu deren herstellung
AU774563B2 (en) Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same
AT360030B (de) Verfahren zur herstellung neuer chinazolon- derivate und ihrer salze
AT400567B (de) Neue arylsubstituierte thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung
DE10122895A1 (de) Neue Lactam-substituierte Pyrazolopyridinderivate
DE3701737A1 (de) 1h-pyrido-(2,3-b)(1,4)-thiazine zur therapeutischen behandlung
EP0056114A1 (de) Pyridylaminobenzoesäuren, ihre Herstellung und Verwendung
DE3132754A1 (de) "2-aryl-imidazo(4,5-b)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung"

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7808530-5

Effective date: 19940310

Format of ref document f/p: F